Roles of Peptidases in Chronic Airway Inflammation

肽酶在慢性气道炎症中的作用

基本信息

项目摘要

In inflamed ainvay, changes in epithelial architecture, matrix, glands, and vessels promote obstruction and hypersecretion in chronic bronchitis and asthma. This project tests the hypothesis that peptidases control resolution of remodeling and other aspects of chronic ainway inflammafion. It uses novel approaches such as targeting peptidases in living cells with acfivity-based probes, probing immune cell interactions with real time imaging in mouse models of chronic infection, and exploring contribufions of genetic variation in mast cell peptidases to human asthma. Aim 1 is to determine roles of the ainway epithelial peptidase prostasin in chronic infection. Epithelial integrity and hydrafion is essenfial for defense against microbes and toxins. Failure of barrier funcfion leads to chronic infection and remodeling, as in cystic fibrosis. Aim 1 studies test the hypothesis that prostasin support of ainway ion flux and integrity is controlled by membrane anchoring, acfivafion, inhibition and shedding. Aim 2 is to determine roles of mast cell peptidases in resolving inflammafion. Mast cell products can Inflict harm, but mouse studies suggest they also promote survival from septic peritonitis and pneumonia. By helping to resolve infection, their overall effect can be anti-inflammatory. Aim 2 studies test the hypothesis that mast cell pepfidases promote resolufion of chronic inflammation. Aim 3 is to determine impact of mast cell tryptase deficiency on chronic ainway inflammation. Tryptases are implicated in airway remodeling in allergic and autoimmune inflammation and in defense against bacterial infection and thus have the potential to produce as well as to resolve inflammation. Our recent work reveals that dysfunctional human tryptases are common and that Individuals and populafions vary strikingly in number of active tryptase genes inherited. By exploring connecfions between genotype and asthma, a disease associated not only with chronic inflammafion but with exacerbation by infection, the proposed studies test the hypothesis that differences in tryptase genotype contribute to inherited variafion in asthma severity and suscepfibility. Overall, the proposed studies are expected to identify mechanisms that suggest previously unexplored strategies to prevent or reverse the pathology of chronic airway inflammation.
在发炎的血管中,上皮结构、基质、腺体和血管的变化促进了阻塞 以及慢性支气管炎和哮喘的高分泌。这个项目检验了肽酶 控制慢性气道炎症的重塑和其他方面的消退。它使用新颖的方法 例如用基于活性的探针靶向活细胞中的肽酶,探测免疫细胞与 慢性感染小鼠模型的真实的时间成像,并探索 肥大细胞肽酶对人类哮喘的影响。目的1是确定气道上皮肽酶的作用 前列腺素在慢性感染中的作用上皮完整性和水合作用对于防御微生物和 毒素屏障功能的失效导致慢性感染和重塑,如囊性纤维化。要求1 研究验证了前列腺素对通道离子通量和完整性的支持是由膜控制的假设 锚定、激活、抑制和脱落。目的二是确定肥大细胞肽酶在解决 炎症肥大细胞产物可能会造成伤害,但小鼠研究表明,它们也可以促进从 脓毒性腹膜炎和肺炎。通过帮助解决感染,它们的整体效果可以是抗炎的。 目的2验证肥大细胞肽酶促进慢性炎症消退的假说。目标3 确定肥大细胞类胰蛋白酶缺乏对慢性气道炎症影响。胰蛋白酶是 与过敏性和自身免疫性炎症的气道重塑有关, 感染,因此有可能产生并解决炎症。我们最近的研究揭示了 功能失调的人类类胰蛋白酶是常见的,个体和人群在 遗传的活性类胰蛋白酶基因的数量。通过探索基因型和哮喘之间的联系, 不仅与慢性炎症有关,而且与感染加重有关, 研究验证了类胰蛋白酶基因型差异导致哮喘遗传变异的假设 严重性和可重复性。总的来说,拟议的研究预计将确定机制,表明 以前未探索的预防或逆转慢性气道炎症病理学的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE H CAUGHEY其他文献

GEORGE H CAUGHEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE H CAUGHEY', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    8239551
  • 财政年份:
    2011
  • 资助金额:
    $ 32.84万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7931088
  • 财政年份:
    2010
  • 资助金额:
    $ 32.84万
  • 项目类别:
Roles of Peptidases in Chronic Airway Inflammation
肽酶在慢性气道炎症中的作用
  • 批准号:
    7931085
  • 财政年份:
    2010
  • 资助金额:
    $ 32.84万
  • 项目类别:
Proteases in Airway Remodeling and Host Defense
气道重塑和宿主防御中的蛋白酶
  • 批准号:
    6955249
  • 财政年份:
    2004
  • 资助金额:
    $ 32.84万
  • 项目类别:
Core A--Administration Core
核心A--管理核心
  • 批准号:
    6955303
  • 财政年份:
    2004
  • 资助金额:
    $ 32.84万
  • 项目类别:
EXTRACELLULAR PROTEASES IN INFLAMMATORY AIRWAY REMODELING
炎症性气道重塑中的细胞外蛋白酶
  • 批准号:
    6781170
  • 财政年份:
    2003
  • 资助金额:
    $ 32.84万
  • 项目类别:
EXTRACELLULAR PROTEASES IN INFLAMMATORY AIRWAY REMODELING
炎症性气道重塑中的细胞外蛋白酶
  • 批准号:
    6616336
  • 财政年份:
    2002
  • 资助金额:
    $ 32.84万
  • 项目类别:
HUMAN MAST CELL CHYMASE AND CATHEPSIN G EXPRESSION IN AIRWAY INFLAMMATION
气道炎症中人肥大细胞糜酶和组织蛋白酶 G 的表达
  • 批准号:
    6662166
  • 财政年份:
    2002
  • 资助金额:
    $ 32.84万
  • 项目类别:
EXTRACELLULAR PROTEASES IN INFLAMMATORY AIRWAY REMODELING
炎症性气道重塑中的细胞外蛋白酶
  • 批准号:
    6491089
  • 财政年份:
    2001
  • 资助金额:
    $ 32.84万
  • 项目类别:
HUMAN MAST CELL CHYMASE AND CATHEPSIN G EXPRESSION IN AIRWAY INFLAMMATION
气道炎症中人肥大细胞糜酶和组织蛋白酶 G 的表达
  • 批准号:
    6355584
  • 财政年份:
    2000
  • 资助金额:
    $ 32.84万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 32.84万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 32.84万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 32.84万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 32.84万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 32.84万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 32.84万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 32.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了